SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Thomas Haegin who wrote (642)12/22/1997 7:15:00 PM
From: Christopher White  Read Replies (2) | Respond to of 2068
 
OXHP downgraded by Value Line to a timeliness of of 4 (below average). VL estimates the company will lose $1.97/share in FY97 and will earn $0.50/share in FY98.

Christopher



To: Thomas Haegin who wrote (642)12/24/1997 6:56:00 PM
From: Premier  Read Replies (1) | Respond to of 2068
 
Thomas,

Times reported today:

OXHP will have to raise capital. The sources of new capital could be debt, preferred stock,common stock, sale of minority interest or increase of premiums. OXHP does not need approval of regulators if premium increase is limited to 10%.

Happy holidays.

Premier


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News